Latest news
Immune Mediated Disease Therapeutics Developer Attovia Therapeutics Debuts on Nasdaq - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 10:46:00 GMTAttovia Therapeutics, Developer of Next‑Generation Biotherapeutics for Immune‑Mediated Diseases, Files for Nasdaq IPO - tradingview.comtradingview.com · Wed, 05 Aug 2026 20:09:00 GMTVaccinating Patients With Immune-Mediated Inflammatory Diseases - Cleveland ClinicCleveland Clinic · Wed, 05 Aug 2026 05:26:44 GMTTissue-resident immune cells drive genetic risk in autoimmune and lung diseases - NatureNature · Mon, 03 Aug 2026 10:38:37 GMT